304 related articles for article (PubMed ID: 10641091)
1. [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report].
Gavriş M; Neamţu S; Gavriş S; Ghiţuică A
Oftalmologia; 1999; 46(1):69-71. PubMed ID: 10641091
[TBL] [Abstract][Full Text] [Related]
2. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
4. Treatment of overt extraocular retinoblastoma.
Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
6. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
Chantada GL; Casco F; Fandiño AC; Galli S; Manzitti J; Scopinaro M; Schvartzman E; de Dávila MT
Ophthalmology; 2007 Nov; 114(11):2083-9. PubMed ID: 17459482
[TBL] [Abstract][Full Text] [Related]
8. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
[TBL] [Abstract][Full Text] [Related]
9. [Study on the risk factors for optic nerve invasion in 381 cases of retinoblastoma].
Ren RJ; Li B; Li LQ; Sun XL
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):489-92. PubMed ID: 17897523
[TBL] [Abstract][Full Text] [Related]
10. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.
Chantada GL; Doz F; Orjuela M; Qaddoumi I; Sitorus RS; Kepak T; Furmanchuk A; Castellanos M; Sharma T; Chevez-Barrios P; Rodriguez-Galindo C;
Pediatr Blood Cancer; 2008 Mar; 50(3):692-4. PubMed ID: 18059037
[TBL] [Abstract][Full Text] [Related]
11. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve.
Chantada GL; Guitter MR; Fandiño AC; Raslawski EC; de Davila MT; Vaiani E; Scopinaro MJ
Pediatr Blood Cancer; 2009 Feb; 52(2):218-22. PubMed ID: 18937327
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma in Turkey--treatment and prognosis.
Günalp I; Gündüz K; Arslan Y
Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506
[TBL] [Abstract][Full Text] [Related]
14. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis.
Armenian SH; Panigrahy A; Murphree AL; Jubran RF
Pediatr Blood Cancer; 2008 Oct; 51(4):479-84. PubMed ID: 18478574
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
Kim JW
Int Ophthalmol Clin; 2015; 55(1):77-96. PubMed ID: 25436495
[No Abstract] [Full Text] [Related]
16. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
17. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion.
Choucair ML; Brisse HJ; Fréneaux P; Desjardins L; Dorfmüller G; Puget S; Dendale R; Chevrier M; Doz F; Lumbroso-Le Rouic L; Aerts I
Pediatr Blood Cancer; 2020 Jan; 67(1):e27998. PubMed ID: 31571399
[TBL] [Abstract][Full Text] [Related]
18. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
Wilson MW; Rodriguez-Galindo C; Billups C; Haik BG; Laningham F; Patay Z
Ophthalmology; 2009 Aug; 116(8):1558-63. PubMed ID: 19545904
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
